1'-acetoxychavicol acetate has been researched along with Bone Loss, Osteoclastic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Katsumata, S; Murakami, A; Ohigashi, H; Song, M; Suzuki, K; Uehara, M | 1 |
Aggarwal, BB; Ichikawa, H; Murakami, A | 1 |
2 other study(ies) available for 1'-acetoxychavicol acetate and Bone Loss, Osteoclastic
Article | Year |
---|---|
Citrus nobiletin suppresses bone loss in ovariectomized ddY mice and collagen-induced arthritis in DBA/1J mice: possible involvement of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclastogenesis regulation.
Topics: Animals; Antioxidants; Arthritis, Experimental; Benzyl Alcohols; Blotting, Western; Bone Density; Bone Resorption; Cell Line; Citrus; Coumarins; Female; Flavones; Isothiocyanates; Mice; Mice, Inbred DBA; Molecular Structure; Osteogenesis; Ovariectomy; RANK Ligand; Sesquiterpenes; Terpenes | 2007 |
1'-Acetoxychavicol acetate inhibits RANKL-induced osteoclastic differentiation of RAW 264.7 monocytic cells by suppressing nuclear factor-kappaB activation.
Topics: Animals; Benzyl Alcohols; Bone Resorption; Carrier Proteins; Cell Differentiation; Down-Regulation; Humans; I-kappa B Kinase; Membrane Glycoproteins; Mice; Monocytes; Neoplasms; NF-kappa B; Osteoclasts; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Terpenes; Tumor Cells, Cultured | 2006 |